temozolomide and Infection studies

temozolomide and Infection

temozolomide has been researched along with Infection in 2 studies

Research Excerpts

Excerpt	Relevance	Reference
"The temozolomide is a promising orally cytotoxic agent used in malignant glioma."	8.83	The safety of the temozolomide in patients with malignant glioma. ( Dario, A; Tomei, G, 2006)
"The authors investigated the safety of 75 mg/m2 temozolomide for 21 days every 28 days in glioma patients."	7.73	Is protracted low-dose temozolomide feasible in glioma patients? ( Blatt, V; Brandes, AA; Cavallo, G; Ermani, M; Franceschi, E; Gardiman, M; Ghimenton, C; Pasetto, L; Scopece, L; Tosoni, A, 2006)
"The temozolomide is a promising orally cytotoxic agent used in malignant glioma."	4.83	The safety of the temozolomide in patients with malignant glioma. ( Dario, A; Tomei, G, 2006)
"The authors investigated the safety of 75 mg/m2 temozolomide for 21 days every 28 days in glioma patients."	3.73	Is protracted low-dose temozolomide feasible in glioma patients? ( Blatt, V; Brandes, AA; Cavallo, G; Ermani, M; Franceschi, E; Gardiman, M; Ghimenton, C; Pasetto, L; Scopece, L; Tosoni, A, 2006)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

2 (100.00)

29.6817

2010's

0 (0.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Dario, A	1
Tomei, G	1
Tosoni, A	1
Cavallo, G	1
Ermani, M	1
Scopece, L	1
Franceschi, E	1
Ghimenton, C	1
Gardiman, M	1
Pasetto, L	1
Blatt, V	1
Brandes, AA	1

Studies

Dario, A

Tomei, G

Tosoni, A

Cavallo, G

Ermani, M

Scopece, L

Franceschi, E

Ghimenton, C

Gardiman, M

Pasetto, L

Blatt, V

Brandes, AA

Reviews

1 review available for temozolomide and Infection

Article	Year
The safety of the temozolomide in patients with malignant glioma. Current drug safety, 2006, Volume: 1, Issue:2 Topics: Adult; Antineoplastic Agents, Alkylating; Child; Clinical Trials as Topic; Dacarbazine; Drug Interac	2006

Article

Year

The safety of the temozolomide in patients with malignant glioma.

Current drug safety, 2006, Volume: 1, Issue:2

Topics: Adult; Antineoplastic Agents, Alkylating; Child; Clinical Trials as Topic; Dacarbazine; Drug Interac

2006

Other Studies

1 other study available for temozolomide and Infection

Article	Year
Is protracted low-dose temozolomide feasible in glioma patients? Neurology, 2006, Feb-14, Volume: 66, Issue:3 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Central Nervous System Neoplasms; Dacarbazine; Dose-	2006

Article

Year

Is protracted low-dose temozolomide feasible in glioma patients?

Neurology, 2006, Feb-14, Volume: 66, Issue:3

Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Central Nervous System Neoplasms; Dacarbazine; Dose-

2006